The socioeconomic status and quality of life in patients with chronic obstructive pulmonary disease

Tanaffos

Volumn 6, Issue 2, 2007, Pages 38-45

  Aslani, Jafar ^a   Nouhi, Sima ^a   AzizAbadi Farahani, Mahdi ^a   Moghani Lankarani, Maryam ^a   Saadat, Seyed Hassan ^a   Ghanel, Mostafa ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic obstructive pulmonary disease; Income level; Quality of Life; Socioeconomic status

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; EDUCATION; EMOTIONAL DISORDER; FEMALE; HEALTH INSURANCE; HEALTH STATUS; HOUSEHOLD; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL HEALTH; PAIN ASSESSMENT; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; QUALITY OF LIFE; SEX DIFFERENCE; SHORT FORM 36; SOCIAL INTERACTION; SOCIAL STATUS; SPIROMETRY;

EID: 77953395516     PISSN: 17350344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ramsey SD, Sullivan SD. The burden of illness and economic evaluation for COPD. Eur Respir J Suppl 2003; 41: 29s-35s.
2. Prescott E, Vestbo J. Socioeconomic status and chronic obstructive pulmonary disease. Thorax 1999; 54 (8): 737-41.
3. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117 (2 Suppl): 5S-9S.
4. Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996; 274 (5288): 740-3.
5. Statistiques des causes medicales de deces. Paris: Editions INSERM, 1990
6. Pelletier-Fleury N, Lanoe JL. Fleury B, Fardeau M. The cost of treating COPD patients with long-term oxygen therapy in a French population. Chest 1996; 110 (2): 411-6.
7. Sullivan SD, Buist AS, Weiss K. Health outcomes assessment and economic evaluation in COPD: Challenges and opportunities. Eur Respir J Suppl 2003; 41: 1s-3s.
8. Ketelaars CA, Schlosser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, and Wouters EF. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 39-43.
9. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996; 51 (1): 44-7.
10. Monso E, Fiz JM, Izquierdo J, Alonso J, Coll R, Rosell A, et al. Quality of life in severe chronic obstructive pulmonary disease: Correlation with lung and muscle function. Respir Med 1998; 92 (2): 221-7.
11. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997; 127 (12): 1072-9.
12. Jones PW. Quality of life measurement for patients with diseases of the airways. Thorax 1991; 46 (9): 676-82.
13. Ferrer M, Alonso J, Prieto L, Plaza V, Monso E, Marrades R, et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: The Spanish example. Eur Respir J 1996; 9 (6): 1160-6.
14. Schrier AC, Dekker FW, Kaptein AA, Dijkman JH. Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. Chest 1990; 98 (4): 894-9.
15. McSweeny AJ, Grant I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982; 142 (3): 473-8.
16. Prigatano GP, Wright EC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med 1984; 144 (8): 1613-9.
17. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8 (8): 1398-420.
18. Risk Factors For COPD (Based on the 2005 update of the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease - sponsored by NHLBI, and WHO.) This information has been approved by Scott Glenn Van Da Walker, C-FNP, MSN, RN (March 2006).
19. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28 (2): 193-213.
20. Ware JE, Kosinski M, Keller SK. Physical and Mental Health Summary Scales. A User's Manual. The Health Institute, Boston, MA, 1994
21. Soyyiǧit S, Erk M, Güler N, Kilinç G. The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease. Tuberk Toraks 2006; 54 (3): 259-66.
22. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): Translation and validation study of the Iranian version. Qual Life Res 2005; 14 (3): 875-82.
23. Ifudu O, Paul HR, Homel P, Friedman EA. Predictive value of functional status for mortality in patients on maintenance hemodialysis. Am J Nephrol 1998; 18 (2): 109-16.
24. Ifudu O, Paul HR, et al. Predictive value of functional Status for mortality in patients on maintenance hemodialysis. Am J Nephrol 1998; 18: 109-16.
25. Sant'Anna CA, Stelmach R, Zanetti Feltrin MI, Filho WJ, Chiba T, Cukier A. Evaluation of health-related quality of life in low-income patients with COPD receiving long-term oxygen therapy. Chest 2003; 123 (1): 136-41.
26. Gu B. Population, environment dynamics, poverty and quality of life in China. China Popul Today 1996; 13 (5-6): 17-20.
27. The Impact of Poverty on Health: A Scan of Research Literature. (2003) Ottawa: Canadian Population Health Initiative. Canadian Institute for Health RDsearch: Available at: dsp-psd.communication.gc.ca/Collectioni/ H118-11-2003-1E.pdf
28. Coppin AK, Ferrucci L, Lauretani F, Phillips C, Chang M, Bandinelli S, et al. Low socioeconomic status and disability in old age: Evidence from the InChianti study for the mediating role of physiological impairments. J Gerontol A Biol Sci Med Sci 2006; 61 (1): 86-91.
29. Sullivan SD, Strassels SA, Smith DH. Characterization of the costs of chronic obstructive pulmonary disease (COPD) in the US [abstract]. Eur Respir J 1996; 9(suppl 23):421S.
30. Grasso ME, Weller WE, Shaffer TJ, Diette GB, Anderson GF. Capitation, managed care, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158 (1): 133-8.
31. Global Initiative for Chronic Obstructive Pulmonary Disease. Burden of COPD. http://www.goldcopd/workshop/ch2.html. May 2000. Accessed May 3, 2002.
32. World Health Report; 2005. Annex 5, http://www.who.int/nha/country/ whrannex/en/.
33. Ettner SL, Grzywacz JG. Socioeconomic status and health among Californians: An examination of multiple pathways. Am J Public Health 2003; 93 (3): 441-4.
34. Gordon EJ, Prohaska T, Siminoff LA, Minich PJ, Sehgal AR. Can focusing on self-care reduce disparities in kidney transplantation outcomes? Am J Kidney Dis 2005; 45 (5): 935-40.
35. Mulrow CD, Gerety MB, Cornell JE, Lawrence VA, Kanten DN. The relationship between disease and function and perceived health in very frail elders. J Am Geriatr Soc 1994; 42 (4): 374-80.
36. Harter M. Etiology of mental disorders in chronic somatic illness. Rehabilitation (Stuttg) 2002; 41 (6): 357-66.
37. Woodward RS, Schnitzler MA, Lowell JA, Spitznagel EL, Brennan DC. Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants. Am J Transplant 2001; 1 (1): 69-73.
38. Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: Results from the Copenhagen City Heart Study. Eur Respir J 1999; 13 (5): 1109-14.
39. Marmot MG, Shipley MJ, Rose G. Inequalities in death - specific explanations of a general pattern? Lancet 1984; 1 (8384): 1003-6.
40. Spencer S, Calverley PM, Sherwood Burge P, Jones PW; ISOLDE Study Group. Inhaled Steroids in Obstructive Lung Disease Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163 (1): 122-8.